Article Versions Notes

Tsai C-C, Su Y-C, Bamodu OA, Chen B-J, Tsai W-C, Cheng W-H, Lee C-H, Hsieh S-M, Liu M-L, Fang C-L, et al. High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan. Cancers. 2021; 13(7):1620. https://doi.org/10.3390/cancers13071620

Tsai, Cheng-Chih, Yung-Cheng Su, Oluwaseun Adebayo Bamodu, Bo-Jung Chen, Wen-Chiuan Tsai, Wei-Hong Cheng, Chii-Hong Lee, Shu-Min Hsieh, Mei-Ling Liu, Chia-Lang Fang, and et al. 2021. "High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan" Cancers 13, no. 7: 1620. https://doi.org/10.3390/cancers13071620

Tsai, C.-C., Su, Y.-C., Bamodu, O. A., Chen, B.-J., Tsai, W.-C., Cheng, W.-H., Lee, C.-H., Hsieh, S.-M., Liu, M.-L., Fang, C.-L., Lin, H.-T., Chen, C.-L., Yeh, C.-T., Lee, W.-H., Ho, C.-L., Lai, S.-W., Tzeng, H.-E., Hsieh, Y.-Y., Chang, C.-L., ... Chao, T.-Y. (2021). High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan. Cancers, 13(7), 1620. https://doi.org/10.3390/cancers13071620